查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677008

蛋白质体学服务市场：按类型、按样本类型、按服务类型、按技术、按应用和按最终用户 - 2025-2030 年全球预测

Proteomics Service Market by Type, Sample Type, Service Type, Technology, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

蛋白质体学服务市场预计在 2024 年价值为 55.2 亿美元，在 2025 年达到 61.3 亿美元，复合年增长率为 11.34%，到 2030 年达到 105.1 亿美元。

主要市场统计数据
基准年 2024 年 55.2亿美元
预计 2025 年 61.3亿美元
预测年份 2030 105.1亿美元
复合年增长率（%） 11.34％

蛋白质体学服务已成为现代生命科学和生物技术的重要支柱，重新定义了我们理解细胞过程和疾病机制的方式。透过分析蛋白质体（生物体表达的整个蛋白质组），科学家可以获得推动基础研究和临床应用的宝贵见解。在当今快节奏的研究环境中，蛋白质体学服务将技术创新与科学发现独特地融合在一起，使研究人员能够以前所未有的精度解读复杂的生物系统。

分析技术、资料处理和高通量筛检的最新进展使蛋白质体学处于个人化医疗、生物标记发现和药物发现的前沿。这种演变不仅改变了学术研究，也重塑了製药、生物技术和临床诊断等产业所采用的策略。随着研究机构和商业公司不断应对复杂的生物学挑战，对可靠、高效和可扩展的蛋白质体学服务的需求从未如此高涨。

这个市场的动态特性源自于对实现全面蛋白质分析的技术和尖端仪器开发的持续投资。这些创新方法将有助于准确识别和量化蛋白质，从而为有针对性的治疗性介入开闢新的途径。总体而言，蛋白质体学领域的持续变化为相关人员提供了重大机会，使其能够推进科学发现，同时解决未满足的临床需求。

改变蛋白质体学服务市场

蛋白质体学服务领域正在经历变革时期，这场变革正在彻底改变科学研究的进行方式。在过去的十年中，技术的快速进步提高了蛋白质分析的精度、扩充性和速度，开创了发现和应用的新时代。这一转变的核心是将尖端仪器与强大的分析框架相结合，以支援高通量分析且不影响可靠性。

下一代质谱仪和先进的层析法技术等创新使研究人员能够以更高的分辨率和灵敏度检测到蛋白质表现中最细微的变化。这些进步正在推动从传统的手动方法向自动化、精简的工作流程的转变，从而减少错误并提高可重复性。此外，数位数位资料分析和机器学习演算法的兴起使得对大型资料集的全面处理成为可能，从而有助于获得以前由于计算限製而无法获得的洞察力。

此外，标准化协议和品管措施的广泛采用有助于弥合研究与临床应用之间的差距。这一发展凸显了整个产业向个人化医疗的转变，其中蛋白质体学在分子层面上理解疾病机制方面发挥关键作用。技术创新与简化的资料处理的相互作用不仅加速了发现，而且使蛋白质组学服务成为现代医疗保健和研究工作中的重要工具。

蛋白质体学服务市场的关键细分见解

蛋白质体学服务市场的详细细分阐明了定义这一动态领域的各种方法、分析技术和应用。按类型细分市场表明，表达蛋白质组学、功能蛋白质组学和结构蛋白质组学各自对整体分析工作流程做出了独特的贡献。表达蛋白质体学关注不同生物状态下蛋白质的量化和变化，而功能性蛋白质体学旨在了解蛋白质的相互作用和功能。另一方面，结构蛋白质体学提供了对蛋白质的3D结构以及它如何影响其功能和相互作用的深入了解。

以样本类型检查分割可以发现重要的差异。这些包括体液样本（其中的生物标记可能指示疾病状态）、细胞样本（可用于探索细胞内过程）以及病理学）。每种样品类型都需要独特的製备策略和分析方法，这将影响您对蛋白质体学服务的选择。

市场根据服务类型进一步细分，例如生物资讯学和资料分析、化学和蛋白质组学分析服务、蛋白质鑑定、蛋白质定量和样品製备服务。这些相互关联的服务促进了从原始样本处理到可操作见解的无缝过渡。技术也发挥基础性的作用，层析法、电泳法、质谱法、蛋白质微阵列和X射线结晶等技术引领分析。尤其是层析法，它与气相层析法和高效液相层析(HPLC) 提供了互补方法，而电泳法则则透过毛细管电泳和凝胶电泳技术扩展了其效用。

此外，市场细分突显了农业和食品安全、临床诊断和药物发现的重大贡献。在农业和食品安全领域，污染物检测和品管至关重要，而在临床诊断领域，蛋白质体学资料可用于癌症诊断和感染疾病评估。在药物发现中，生物标记发现和目标识别协议将影响治疗创新。最后，对学术机构、受託研究机构、医院、诊断实验室、製药公司和生物技术公司等最终用户领域的关注，凸显了蛋白质体学服务在不同领域的广泛影响和整合。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 个人化医疗需求不断成长将推动蛋白质体学市场的成长
      • 质谱和人工智慧的进步提高了蛋白质分析的准确性
      • 增加对蛋白质体学驱动的药物发现和生物标记研究的投资
    • 限制因素
      • 新兴市场蛋白质体学技术高成本且取得途径有限
    • 机会
      • 蛋白质体学在早期疾病检测和标靶治疗的进展
      • 拓展蛋白质体学在临床诊断与精准医疗的应用
    • 任务
      • 了解全球蛋白质体学技术的复杂监管要求
  • 市场区隔分析
    • 样本类型：增加体液样本的使用并强调非侵入性诊断程序
    • 最终用户：对个人化医疗的日益偏好推动了蛋白质体学服务市场的发展
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

6. 蛋白质体学服务市场按类型

  • 表达蛋白质体学
  • 功能蛋白质体学
  • 结构蛋白质体学

7. 蛋白质体学服务市场（依样本类型）

  • 体液样本
  • 细胞样本
  • 组织样本

8. 蛋白质体学服务市场（依服务类型）

  • 生物资讯学和资料分析
  • 化学蛋白质体学分析服务
  • 蛋白质鑑定
  • 蛋白质定量
  • 样品製备服务

9. 蛋白质体学服务市场（依技术）

  • 层析法
    • 气相层析法
    • 高效液相层析(HPLC)
  • 电泳
    • 毛细管电泳
    • 凝胶电泳
  • 质谱分析
  • 蛋白质微阵列
  • X射线结晶

第 10 章 蛋白质体学服务市场（按应用）

  • 农业和食品安全
    • 污染物检测
    • 品管
  • 临床诊断
    • 癌症诊断
    • 感染疾病诊断
  • 药物研发
    • 生物标记发现
    • 目标识别

第 11 章 蛋白质体学服务市场（按最终用户）

  • 学术研究所
  • 合约研究组织
  • 医院和诊断实验室
  • 製药和生物技术公司

12. 美洲蛋白质体学服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

13. 亚太蛋白质体学服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

14. 欧洲、中东和非洲蛋白质体学服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十五章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Agilent Technologies, Inc.
  • Alphalyse A/S
  • Applied Biomics, Inc.
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Biogenity ApS
  • Biognosys AG
  • Bruker Corporation
  • CD Genomics
  • CovalX AG
  • Creative Proteomics
  • Danaher Corporation
  • Eurofins EAG Materials Sciences LLC
  • Evosep ApS
  • Illumina, Inc.
  • JPT Peptide Technologies GmbH
  • Merck KGaA
  • Meta Biosciences Pvt Ltd.
  • Metware Biotechnology Inc.
  • MS Bioworks LLC
  • OmicScouts GmbH
  • PerkinElmer Inc.
  • PolyQuant GmbH
  • Proteome Factory AG
  • Proteomics International Pty Ltd.
  • Rapid Novor Inc.
  • Thermo Fisher Scientific Inc
  • VProteomics
  • Waters Corporation
Product Code: MRR-3F3F10CD75C0

The Proteomics Service Market was valued at USD 5.52 billion in 2024 and is projected to grow to USD 6.13 billion in 2025, with a CAGR of 11.34%, reaching USD 10.51 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 5.52 billion
Estimated Year [2025] USD 6.13 billion
Forecast Year [2030] USD 10.51 billion
CAGR (%) 11.34%

Proteomics services have emerged as a critical pillar in modern life sciences and biotechnology, redefining the way we understand cellular processes and disease mechanisms. By analyzing the proteome - the entire set of proteins expressed by an organism - scientists gain valuable insights that drive both fundamental research and clinical applications. In today's fast-paced research environment, proteomics services offer a unique blend of technological innovation and scientific discovery, enabling researchers to decode complex biological systems with unprecedented accuracy.

Recent advancements in analytical techniques, data processing, and high-throughput screening have positioned proteomics at the forefront of personalized medicine, biomarker exploration, and drug discovery. This evolution is not only transforming academic research but is also reshaping the strategies employed by industries such as pharmaceuticals, biotechnology, and clinical diagnostics. As research organizations and commercial enterprises continue to confront intricate biological challenges, the demand for reliable, efficient, and scalable proteomics services has never been higher.

The dynamic nature of this market stems from continual investments in technology and the development of state-of-the-art instrumentation that allows for comprehensive protein analysis. These innovative methods help in precisely identifying and quantifying proteins, thereby opening new avenues for targeted therapeutic interventions. Overall, the ongoing shifts in the proteomics landscape present significant opportunities for stakeholders to drive scientific discovery while simultaneously addressing unmet clinical needs.

Transformative Shifts in the Proteomics Service Landscape

The proteomics services field is undergoing transformative changes that are revolutionizing the way scientific investigations are conducted. Over the past decade, rapid technological advancements have enhanced the precision, scalability, and speed of protein analysis, thereby ushering in a new era of discovery and application. At the heart of these shifts is the integration of cutting-edge instrumentation with robust analytical frameworks that support high-throughput analysis without compromising on reliability.

Innovations such as next-generation mass spectrometry and advanced chromatography techniques have allowed researchers to achieve higher resolution and sensitivity in detecting even the most subtle changes in protein expression. These advances are catalyzing a shift from traditional, manual methods to automated, streamlined workflows that reduce error and improve reproducibility. Furthermore, the rise of digital data analytics and machine learning algorithms has enabled the comprehensive processing of large datasets, facilitating insights that were previously out of reach due to computational limitations.

Additionally, the broader adoption of standardized protocols and quality control measures has helped in bridging the gap between research and clinical applications. This progression underscores an industry-wide move towards personalized medicine, where proteomics plays a pivotal role in understanding disease mechanisms at a molecular level. The interplay between technological innovations and streamlined data handling not only accelerates discoveries but also positions proteomics services as an indispensable tool in modern healthcare and research endeavors.

Key Segmentation Insights in Proteomics Services Market

A detailed segmentation of the proteomics services market elucidates the diverse methodologies, analytical techniques, and applications that define this dynamic field. When categorizing the market based on type, it becomes evident that expression proteomics, functional proteomics, and structural proteomics each contribute uniquely to the overall analysis workflow. Expression proteomics focuses on protein quantification and variation under different biological states, while functional proteomics is geared towards understanding protein interactions and functions. Structural proteomics, on the other hand, provides insights into the three-dimensional conformation of proteins and its implications on function and interaction.

Examining the segmentation by sample type reveals critical distinctions. Studies involve body fluid samples where biomarkers may represent disease states, cell samples that allow the exploration of intracellular processes, and tissue samples which often provide comprehensive profiles in pathophysiological contexts. Each sample type demands specific preparation strategies and analytical methods, which in turn influence the choice of proteomics service.

The market is further segmented by service type, encompassing bioinformatics and data analysis, chemical proteomics analysis services, protein identification, protein quantification, and sample preparation services. The interconnectedness of these offerings facilitates a seamless transition from raw sample processing to actionable insights. Technology also plays a fundamental role, with methods such as chromatography, electrophoresis, mass spectrometry, protein microarray, and X-ray crystallography leading the analytical charge. Here, chromatography is particularly notable, with gas chromatography and high-performance liquid chromatography (HPLC) providing complementary approaches, while electrophoresis extends its utility through capillary electrophoresis and gel electrophoresis techniques.

Furthermore, market application segmentation underlines the significant contributions of agriculture and food safety, clinical diagnostics, and drug discovery. In agriculture and food safety, contaminant detection and quality control are paramount, whereas clinical diagnostics leverage proteomic data for cancer diagnostics and infectious disease evaluations. Drug discovery stands to benefit from biomarker discovery and target identification protocols that direct therapeutic innovation. Finally, the focus on end-user segments such as academic research institutions, contract research organizations, hospitals and diagnostic laboratories, and pharmaceuticals and biotechnology companies underscores the widespread impact and integration of proteomics services across diverse sectors.

Based on Type, market is studied across Expression Proteomics, Functional Proteomics, and Structural Proteomics.

Based on Sample Type, market is studied across Body Fluid Samples, Cell Samples, and Tissue Samples.

Based on Service Type, market is studied across Bioinformatics & Data Analysis, Chemical Proteomics Analysis Service, Protein Identification, Protein Quantification, and Sample Preparation Service.

Based on Technology, market is studied across Chromatography, Electrophoresis, Mass Spectrometry, Protein Microarray, and X-Ray Crystallography. The Chromatography is further studied across Gas Chromatography and High-Performance Liquid Chromatography (HPLC). The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis.

Based on Application, market is studied across Agriculture & Food Safety, Clinical Diagnostics, and Drug Discovery. The Agriculture & Food Safety is further studied across Contaminant Detection and Quality Control. The Clinical Diagnostics is further studied across Cancer Diagnostics and Infectious Disease Diagnostics. The Drug Discovery is further studied across Biomarker Discovery and Target Identification.

Based on End-User, market is studied across Academic Research Institutions, Contract Research Organizations, Hospitals & Diagnostic Labs, and Pharmaceuticals & Biotechnology Companies.

Regional Overview of the Global Proteomics Service Market

An evaluation of the proteomics services market from a regional perspective highlights distinct growth trends and investment opportunities across the globe. In the Americas, robust research funding, state-of-the-art infrastructure, and a strong presence of biotechnology firms have made the region a leader in adopting advanced proteomics solutions. This region benefits from a well-established network of research institutions and hospitals that actively collaborate on translational research projects and clinical trials, further bolstering the demand for precision proteomics services.

Moving to Europe, the Middle East, and Africa, there exists a unique blend of innovation driven by governmental support and cross-border research collaborations. European countries are at the forefront of establishing standardized practices and regulatory frameworks that enhance the translation of proteomics research into clinical applications. Meanwhile, emerging markets in the Middle East and Africa are gradually scaling up their research capacities, driven by investments in biotechnology and an increasing awareness of the value of proteomics in addressing regional health challenges.

The Asia-Pacific region represents one of the fastest-growing segments in the global proteomics market. Rapid industrialization, significant public and private investments in research and development, and a burgeoning pharmaceutical sector are key drivers in this region. The collaborative efforts between academic institutions and industry have propelled the adoption of next-generation proteomics tools, fostering a competitive landscape where innovation serves as a critical success factor. Overall, each of these regions brings a unique set of strengths and challenges to the global proteomics services market, creating a multifaceted and ever-evolving landscape.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Industry Players and Their Impact on the Market

The influence of leading companies in the proteomics services sector cannot be overstated, as they drive technological innovation, improve service quality, and expand market reach. Major players such as Agilent Technologies, Inc. and Alphalyse A/S have set high benchmarks by integrating sophisticated analytical instruments with user-friendly software solutions. In parallel, organizations like Applied Biomics, Inc. and BGI Group have been instrumental in developing comprehensive platforms that meld sample processing with cutting-edge data analytics.

The landscape is further enriched by companies like Bio-Rad Laboratories, Inc. and Biogenity ApS, whose practical solutions for protein identification and quantification are widely adopted in both academic and clinical settings. Firms such as Biognosys AG and Bruker Corporation continue to push the boundaries of instrumentation, ensuring that researchers have access to the latest innovations in mass spectrometry and electrophoresis technologies. Other influential names include CD Genomics and CovalX AG, which provide tailored offerings that address specific research needs.

Companies like Creative Proteomics and Danaher Corporation focus on enhancing the reproducibility and scalability of proteomics workflows, while Eurofins EAG Materials Sciences LLC and Evosep ApS excel in streamlining data integration processes. Esteemed organizations including Illumina, Inc., JPT Peptide Technologies GmbH, and Merck KGaA drive collaborative innovation, leveraging their extensive research networks to facilitate breakthroughs in proteomics technologies.

Additional significant contributors such as Meta Biosciences Pvt Ltd., Metware Biotechnology Inc., MS Bioworks LLC, and OmicScouts GmbH are consistently working to reduce turnaround times and improve data fidelity, ensuring that proteomics research remains at the cutting edge. Finally, industry stalwarts like PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc., VProteomics, and Waters Corporation continue to shape market trends through relentless research and innovation, further solidifying the global footprint of proteomics services in both academic and commercial circuits.

The report delves into recent significant developments in the Proteomics Service Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alphalyse A/S, Applied Biomics, Inc., BGI Group, Bio-Rad Laboratories, Inc., Biogenity ApS, Biognosys AG, Bruker Corporation, CD Genomics, CovalX AG, Creative Proteomics, Danaher Corporation, Eurofins EAG Materials Sciences LLC, Evosep ApS, Illumina, Inc., JPT Peptide Technologies GmbH, Merck KGaA, Meta Biosciences Pvt Ltd., Metware Biotechnology Inc., MS Bioworks LLC, OmicScouts GmbH, PerkinElmer Inc., PolyQuant GmbH, Proteome Factory AG, Proteomics International Pty Ltd., Rapid Novor Inc., Thermo Fisher Scientific Inc, VProteomics, and Waters Corporation. Actionable Recommendations for Proteomics Service Market Leaders

For industry leaders aiming to secure a competitive edge in the rapidly evolving proteomics market, clear and decisive steps must be taken. Embracing advanced automation and integrating state-of-the-art instrumentation can dramatically enhance both the speed and accuracy of protein analysis. Leaders should invest in robust data analytics platforms capable of handling large datasets, thus turning raw data into actionable insights that can drive clinical and research innovations.

It is also critical to foster a culture of continuous improvement by engaging in regular training and upskilling of technical teams. This ensures that organizations maintain a high degree of competency and can adapt to new technological advancements with agility. Additionally, forging strategic partnerships with leading research institutions and technology providers can facilitate the adoption of best practices and create symbiotic relationships that benefit both parties.

Further recommendations include the development of flexible service models that can adapt to the diverse requirements of different end-user segments. Industry players should consider modular approaches that allow customization based on specific sample types, analytical techniques, and application domains. Investing in robust quality assurance protocols and complying with international regulatory standards will also enhance credibility and drive market confidence.

Finally, establishing an innovation hub to continuously monitor emerging trends and disruptive technologies can be a cornerstone for future success. This could involve the creation of dedicated research and development units that work in tandem with operational teams, thereby accelerating the translation of innovative solutions from concept to market-ready applications. These actionable measures, when implemented effectively, can serve as a roadmap for sustaining long-term growth and maintaining leadership in the competitive proteomics services landscape.

Conclusion: Embracing the Future of Proteomics Services

The proteomics services market stands at a pivotal juncture where technological advancement, methodological refinement, and strategic positioning converge to define its future trajectory. As comprehensive protein analysis becomes increasingly central to both research and clinical diagnostics, stakeholders must be prepared to adapt to the rapid pace of innovation. The journey from complex data generation to high-impact actionable insights underscores the essential value of proteomics in addressing unmet scientific and medical needs.

The insights drawn from detailed segmentation, regional evaluation, and competitive analysis call for an integrated approach that balances technological investments with market-driven strategies. By prioritizing quality, scalability, and operational excellence, market players can harness the full potential of laboratory automation, advanced analytics, and data integration. Embracing change and continuously reassessing industry practices will be critical to staying ahead in an environment that is dynamic and increasingly data-centric.

Ultimately, the drive toward precision medicine and personalized therapies will only intensify the demand for superior proteomics services. It is incumbent upon industry leaders to not only recognize these opportunities but to also act decisively in transforming early-stage innovations into market-ready solutions. The future of proteomics is bright, offering unparalleled prospects for advancing our understanding of biology and revolutionizing healthcare.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for personalized medicine driving proteomics market growth
      • 5.1.1.2. Advancements in mass spectrometry and AI enhancing protein analysis precision
      • 5.1.1.3. Increased investment in drug discovery and biomarker research boosting proteomics
    • 5.1.2. Restraints
      • 5.1.2.1. High costs and limited access to proteomics technologies in emerging markets
    • 5.1.3. Opportunities
      • 5.1.3.1. Proteomics advancements in early disease detection and targeted therapies
      • 5.1.3.2. Expansion of proteomics applications in clinical diagnostics and precision healthcare
    • 5.1.4. Challenges
      • 5.1.4.1. Navigating complex regulatory standards for proteomics technologies globally
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Sample Type: Growing use of body fluid samples with increasing emphasis on non-invasive diagnostic procedures
    • 5.2.2. End-User: Rising preference towards personalized medicine boosting the proteomics service market
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Proteomics Service Market, by Type

  • 6.1. Introduction
  • 6.2. Expression Proteomics
  • 6.3. Functional Proteomics
  • 6.4. Structural Proteomics

7. Proteomics Service Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Body Fluid Samples
  • 7.3. Cell Samples
  • 7.4. Tissue Samples

8. Proteomics Service Market, by Service Type

  • 8.1. Introduction
  • 8.2. Bioinformatics & Data Analysis
  • 8.3. Chemical Proteomics Analysis Service
  • 8.4. Protein Identification
  • 8.5. Protein Quantification
  • 8.6. Sample Preparation Service

9. Proteomics Service Market, by Technology

  • 9.1. Introduction
  • 9.2. Chromatography
    • 9.2.1. Gas Chromatography
    • 9.2.2. High-Performance Liquid Chromatography (HPLC)
  • 9.3. Electrophoresis
    • 9.3.1. Capillary Electrophoresis
    • 9.3.2. Gel Electrophoresis
  • 9.4. Mass Spectrometry
  • 9.5. Protein Microarray
  • 9.6. X-Ray Crystallography

10. Proteomics Service Market, by Application

  • 10.1. Introduction
  • 10.2. Agriculture & Food Safety
    • 10.2.1. Contaminant Detection
    • 10.2.2. Quality Control
  • 10.3. Clinical Diagnostics
    • 10.3.1. Cancer Diagnostics
    • 10.3.2. Infectious Disease Diagnostics
  • 10.4. Drug Discovery
    • 10.4.1. Biomarker Discovery
    • 10.4.2. Target Identification

11. Proteomics Service Market, by End-User

  • 11.1. Introduction
  • 11.2. Academic Research Institutions
  • 11.3. Contract Research Organizations
  • 11.4. Hospitals & Diagnostic Labs
  • 11.5. Pharmaceuticals & Biotechnology Companies

12. Americas Proteomics Service Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Proteomics Service Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Proteomics Service Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Illumina collaborates with UK Biobank to advance proteomics with a comprehensive pilot program analyzing 50,000 samples
    • 15.3.2. Quantum-Si's Platinum Pro revolutionizes proteomics with a user-friendly, customizable sequencing platform
    • 15.3.3. Strategic acquisition of Olink by Thermo Fisher Scientific enhances its presence in innovative proteomics services
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Alphalyse A/S
  • 3. Applied Biomics, Inc.
  • 4. BGI Group
  • 5. Bio-Rad Laboratories, Inc.
  • 6. Biogenity ApS
  • 7. Biognosys AG
  • 8. Bruker Corporation
  • 9. CD Genomics
  • 10. CovalX AG
  • 11. Creative Proteomics
  • 12. Danaher Corporation
  • 13. Eurofins EAG Materials Sciences LLC
  • 14. Evosep ApS
  • 15. Illumina, Inc.
  • 16. JPT Peptide Technologies GmbH
  • 17. Merck KGaA
  • 18. Meta Biosciences Pvt Ltd.
  • 19. Metware Biotechnology Inc.
  • 20. MS Bioworks LLC
  • 21. OmicScouts GmbH
  • 22. PerkinElmer Inc.
  • 23. PolyQuant GmbH
  • 24. Proteome Factory AG
  • 25. Proteomics International Pty Ltd.
  • 26. Rapid Novor Inc.
  • 27. Thermo Fisher Scientific Inc
  • 28. VProteomics
  • 29. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. PROTEOMICS SERVICE MARKET MULTI-CURRENCY
  • FIGURE 2. PROTEOMICS SERVICE MARKET MULTI-LANGUAGE
  • FIGURE 3. PROTEOMICS SERVICE MARKET RESEARCH PROCESS
  • FIGURE 4. PROTEOMICS SERVICE MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PROTEOMICS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. PROTEOMICS SERVICE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. PROTEOMICS SERVICE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PROTEOMICS SERVICE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PROTEOMICS SERVICE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEOMICS SERVICE MARKET DYNAMICS
  • TABLE 7. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY EXPRESSION PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY FUNCTIONAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY STRUCTURAL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BODY FLUID SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CELL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TISSUE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BIOINFORMATICS & DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHEMICAL PROTEOMICS ANALYSIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN QUANTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE PREPARATION SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY X-RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CONTAMINANT DETECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY QUALITY CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PROTEOMICS SERVICE MARKET SIZE, BY PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES PROTEOMICS SERVICE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS SERVICE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 308. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 312. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 313. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 314. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 316. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 320. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 321. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 322. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 323. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 324. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 325. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 327. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 330. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 331. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 333. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 335. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 336. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 337. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY AGRICULTURE & FOOD SAFETY, 2018-2030 (USD MILLION)
  • TABLE 338. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 339. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 340. ISRAEL PROTEOMICS SERVICE MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 341. ITALY PROTEOMICS SERVICE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 342. ITALY PROTEOMICS SERVICE MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 343. ITALY PROTEOMICS SERVICE MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 344. ITALY PROTEOMICS SERVICE MARKET SIZE, BY TECHNOLOGY,